Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa

Hormones and Behavior

Volumn 56, Issue 1, 2009, Pages 177-184

  Lowry, Christopher A ^a,b,c   Hale, Matthew W ^b   Burke, Kathleen A ^d   Renner, Kenneth J ^e   Moore, Frank L ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e University of South Dakota   (United States)

Author keywords

5 HT; 5 hydroxytryptamine; Comparative; Corticotropin releasing hormone; CRH; Raphe; Serotonergic; Serotonin; Taricha granulosa

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; NEUROPEPTIDE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AMPHIBIA; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; AROUSAL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORPUS STRIATUM; EMOTIONALITY; FOREBRAIN; HYPOPHYSECTOMY; LOCOMOTION; MALE; NEWT; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SPINAL CORD MOTONEURON; STRESS; VERTEBRATE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; PROSENCEPHALON; RADIOIMMUNOASSAY; SALAMANDRIDAE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 65849134054     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.04.006     Document Type: Article

References (78)

1. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., and Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133 (2005) 983-997
2. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., Watkins L.R., and Maier S.F. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129 (2004) 509-519
3. Barrett J.E., Zhang L., Ahlers S.T., and Wojnicki F.H. Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons. J. Pharmacol. Exp. Ther. 250 (1989) 788-794
4. Bittencourt J.C., and Sawchenko P.E. Do centrally administered neuropeptides access cognate receptors?: An analysis in the central corticotropin-releasing factor system. J. Neurosci. 20 (2000) 1142-1156
5. Bonaz B., and Rivest S. Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am. J. Physiol. 275 (1998) R1438-R1449
6. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Britton D.R., Koob G.F., Rivier J., and Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 31 (1982) 363-367
8. Britton K.T., Lee G., Dana R., Risch S.C., and Koob G.F. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary adrenal system with dexamethasone. Life Sci. 39 (1986) 1281-1286
9. Butler P.D., Weiss J.M., Stout J.C., and Nemeroff C.B. Corticotropin-releasing factor produces fear enhancing and behavioral activating effects following infusion into the locus coeruleus. Neuroscience 10 (1990) 176-183
10. Carpenter R.E., Watt M.J., Forster G.L., Overli O., Bockholt C., Renner K.J., and Summers C.H. Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity. Horm. Behav. 52 (2007) 600-611
11. Carter C.J., and Pycock C.J. The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behaviour, and amphetamine-induced stereotypy. Naunyn-Schmiedebergs Arch. Pharmacol. 308 (1979) 51-54
12. Cazalets J.R., Sqalli-Houssaini Y., and Clarac F. Activation of the central pattern generators for locomotion by serotonin and excitatory amino acids in neonatal rat. J. Physiol. (London) 455 (1992) 187-204
13. Chalmers D.T., Lovenberg T.W., and De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF(2)) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF(1) receptor mRNA expression. J. Neurosci. 15 (1995) 6340-6350
14. 1)-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 420 (2000) 305-323
15. Clements S., and Schreck C.B. Chronic administration of fluoxetine alters locomotor behavior, but does not potentiate the locomotor stimulating effects of CRH in juvenile Chinook salmon (Oncorhynchus tshawytscha). Comp. Biochem. Physiol A Mol. Integr. Physiol. 147 (2007) 43-49
16. Clements S., Moore F.L., and Schreck C.B. Evidence that acute serotonergic activation potentiates the locomotor-stimulating effects of corticotropin-releasing hormone in juvenile chinook salmon (Oncorhynchus tshawytscha) (small star, filled). Horm. Behav. 43 (2003) 214-221
17. Cummings S., Elde R., Ells J., and Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J. Neurosci. 3 (1983) 1355-1368
18. Cummings S.L. Distribution of corticotropin-releasing factor in the cerebellum and precerebellar nuclei of the cat. J. Comp. Neurol. 289 (1989) 657-675
19. Czachura J.F., and Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 362 (2000) 266-275
20. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., and Campeau S. Differential expression of 5HT-1A, alpha(1b) adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 474 (2004) 364-378
21. de Groote L., Penalva R.G., Flachskamm C., Reul J.M.H.M., and Linthorst A.C.E. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. J. Neurochem. 94 (2005) 45-56
22. De Souza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., and Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 5 (1985) 3189-3203
23. Eaves M., Thatcher-Britton K., Rivier J., Vale W., and Koob G.F. Effects of corticotropin-releasing factor on locomotor activity of hypophysectomized rats. Peptides 6 (1985) 923-926
24. Feng N., Mo B., Johnson P.L., Orchinik M., Lowry C.A., and Renner K.J. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res. 1063 (2005) 69-76
25. Feng N., Telefont M., Kelly K., Orchinik M., Forster G.L., Renner K.J., and Lowry C.A. Local perfusion of corticosterone in the rat medial hypothalamus potentiates d-fenfluramine-induced elevations of extracellular 5-HT concentrations. Horm. Behav. (2009) 10.1016/j.yhbeh.2009.03.023
26. Fornal C.A., Martin F.J., Metzler C.W., and Jacobs B.L. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635. J. Pharmacol. Exp. Ther. 291 (1999) 220-228
27. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
28. Gasser P.J., Lowry C.A., and Orchinik M. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J. Neurosci. 26 (2006) 8758-8766
29. Gasser P.J., Orchinik M., Raju I., and Lowry C.A. Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J. Comp. Neurol. 512 (2009) 529-555
30. Grillner S., Wallén P., Dale N., Brodin L., Buchanan J., and Hill R. Transmitters, membrane properties and network circuitry in the control of locomotion in lamprey. Trends Neurosci. 10 (1987) 34-41
31. Harris-Warrick R.M., and Cohen A.H. Serotonin modulates the central pattern generator for locomotion in the isolated lamprey spinal cord. J. Exp. Biol. 116 (1985) 27-46
32. Herrick C.J. The internal structure of the midbrain and thalamus of Necturus. J. Comp. Neurol. (1917) 215-348
33. Herrick C.J. The amphibian forebrain IV. The cerebral hemispheres of Ambystoma. J. Comp. Neurol. 43 (1927) 231-325
34. Herrick C.J. The medulla oblongata of Necturus. J. Comp. Neurol. 50 (1930) 1-96
35. Herrick C.J. The Brain of the Tiger Salamander (1948), University of Chicago Press, Chicago
36. Jordan L.M., Liu J., Hedlund P.B., Akay T., and Pearson K.G. Descending command systems for the initiation of locomotion in mammals. Brain Res. Rev. 57 (2008) 183-191
37. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22 (2000) 148-162
38. Knigge K.M., and Piekut D.T. Distribution of CRF- and tyrosine hydroxylase-immunoreactive neurons in the brainstem of the domestic fowl (Gallus domesticus). Peptides 6 (1985) 97-101
39. Liu J., and Jordan L.M. Stimulation of the parapyramidal region of the neonatal rat brain stem produces locomotor-like activity involving spinal 5-HT7 and 5-HT2A receptors. J. Neurophysiol. 94 (2005) 1392-1404
40. Liu J., and Jordan L.M. Stimulation of the parapyramidal region of the neonatal rat brain stem produces locomotor-like activity involving spinal 5-HT7 and 5-HT2A receptors. J. Neurophysiol. 94 (2005) 1392-1404
41. Lopez A., Mancera J.M., Perez-Figares J.M., and Fernandez-Llebrez P. Immunocytochemical localization of corticotropin-releasing factor in the brain of the turtle, Mauremys caspica. Anat. Embryol. (Berl) 188 (1993) 163-171
42. Lopez-Avalos M.D., Mancera J.M., Perez-Figares J.M., and Fernandez-Llebrez P. Immunocytochemical localization of corticotropin-releasing factor in the brain of the turtle, Mauremys caspica. Anat. Embryol. (Berl) 188 (1993) 163-171
43. Lowry C.A., and Moore F.L. Corticotropin-releasing factor (CRF) antagonist suppresses stress-induced locomotor activity in an amphibian. Horm. Behav. 25 (1991) 84-96
44. Lowry C.A., and Moore F.L. Regulation of behavioral responses by corticotropin-releasing factor. Gen. Comp. Endocrinol. 146 (2006) 19-27
45. Lowry C.A., Deviche P., and Moore F.L. Effects of corticotropin-releasing factor (CRF) and opiates on amphibian locomotion. Brain Res. 513 (1990) 94-100
46. Lowry C.A., Renner K.J., and Moore F.L. Catecholamines and indoleamines in the central nervous system of a urodele amphibian: a microdissection study with emphasis on the distribution of epinephrine. Brain Behav. Evol. 48 (1996) 70-93
47. Lowry C.A., Rose J.D., and Moore F.L. Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian. Horm. Behav. 30 (1996) 50-59
48. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 20 (2000) 7728-7736
49. Lowry C.A., Burke K.A., Renner K.J., Moore F.L., and Orchinik M. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm. Behav. 39 (2001) 195-205
50. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., and Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 8 (2005) 233-246
51. Lowry C.A., Hale M.W., Plant A., Windle R.J., Shanks N., Wood S.A., Ingram C.D., Renner K.J., Lightman S.L., and Summers C.H. Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats. Stress (2008) 1
52. Lukkes J.L., Forster G.L., Renner K.J., and Summers C.H. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens. Eur. J. Pharmacol. 578 (2008) 185-193
53. Mancera J.M., Lopez-Avalos M.D., Perez-Figares J.M., and Fernandez-Llebrez P. The distribution of corticotropin-releasing factor-immunoreactive neurons and nerve fibers in the brain of the snake, Natrix maura. Coexistence with arginine vasotocin and mesotocin. Cell Tissue Res. 264 (1991) 539-548
54. McKay L., Bradberry C., and Oke A. Ascorbic acid oxidase speeds up analysis for catecholamines, indoleamines and their metabolites in brain tissue using high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 311 (1984) 167-169
55. Moore F.L., and Miller L.J. Arginine vasotocin induces sexual behavior of newts by acting on cells in the brain. Peptides 4 (1983) 97-102
56. Moore F.L., and Miller L.J. Stress-induced inhibition of sexual behavior: corticosterone inhibits courtship behaviors of a male amphibian (Taricha granulosa). Horm. Behav. 18 (1984) 400-410
57. Moore F.L., Roberts J., and Bevers J. Corticotropin-releasing factor (CRF) stimulates locomotor activity in intact and hypophysectomized newts (Amphibia). J. Exp. Zool. 231 (1984) 331-333
58. Northcutt R.G., and Kicliter E. Organization of the amphibian telencephalon. In: Ebbesson S.O.E. (Ed). Comparative Neurology of the Telencephalon (2009), Plenum Press, New York 203-255
59. Palkovits M., and Brownstein M.J. Microdissection of brain areas by the punch technique. Proc. Ann. Meet. Soc. Neurosci. (1982) 60-71
60. Palkovits M., and Brownstein M.J. Maps and Guide to Microdissection of the Rat Brain (1988), Elsevier Science Publishing Co., Inc., New York
61. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., and Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 24 (2004) 1305-1311
62. Petersen R.G. Design and Analysis of Experiments (1985), Marcel Dekker, Inc., New York
63. Price M.L., and Lucki I. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J. Neurosci. 21 (2001) 2833-2841
64. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., and Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18 (1998) 492-502
65. Renner K.J., and Luine V.N. Determination of monoamines in brain nuclei by high performance liquid chromatography with electrochemical detection: young vs. middle aged rats. Life Sci. 34 (1984) 2193-2199
66. Renner K.J., and Luine V.N. Analysis of temporal and dose-dependent effects of estrogen on monoamines in brain nuclei. Brain Res. 366 (1986) 64-71
67. Ruggiero D.A., Underwood M.D., Rice P.M., Mann J.J., and Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience 91 (1999) 1343-1354
68. Stanford S.C. Prozac: panacea or puzzle?. Trends Pharmacol. Sci. 17 (1996) 150-154
69. Staub D.R., Spiga F., and Lowry C.A. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res. 1044 (2005) 176-189
70. Staub D.R., Evans A.K., and Lowry C.A. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF(2)) receptors in the regulation of subpopulations of serotonergic neurons. Brain Res. 1070 (2006) 77-89
71. Taber M.T., Kinney G.G., Pieschl R.L., Yocca F.D., and Gribkoff V.K. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections. Synapse 38 (2000) 17-26
72. Valentino R.J., Liouterman L., and Van Bockstaele E.J. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J. Comp. Neurol. 435 (2001) 450-463
73. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., and Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin-I and to corticotropin-releasing factor. Nature 378 (1995) 287-292
74. Veasey S.C., Fornal C.A., Metzler C.W., and Jacobs B.L. Response of serotonergic caudal raphe neurons in relation to specific motor activities in freely moving cats. J. Neurosci. 15 (1995) 5346-5359
75. Verleysdonk S., Hamprecht B., Rapp M., and Wellard J. Uptake and metabolism of serotonin by ependymal primary cultures. Neurochem. Res. 29 (2004) 1739-1747
76. Viana Di Prisco G., Dubuc R., Wallén P., and Grillner S. 5-Hydroxytryptamine modulates spike frequency regulation in reticulospinal neurons involved in the control of locomotion in lamprey. Neurosci. Lett. 134 (1992) 279-283
77. Zhang R., Tachibana T., Takagi T., Koutoku T., Denbow D.M., and Furuse M. Serotonin modifies corticotropin-releasing factor-induced behaviors of chicks. Behav. Brain Res. 151 (2004) 47-52
78. Zoeller R.T., and Moore F.L. Correlation between immunoreactive vasotocin in optic tectum and seasonal-changes in reproductive behaviors of male rough-skinned newts. Horm. Behav. 20 (1986) 148-154